As of 27 Sept 2026, Aristo Bio-Tech & Lifescience Ltd share price is ₹105.85. The stock opened at ₹105.85 and had closed at ₹112.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹74.30 and a high of ₹136.00. In terms of performance, Aristo Bio-Tech & Lifescience Ltd share price has increased by 11.42% over the past six months and has decreased by 16.13% over the last year.
ARISTO Stock Price Chart
Aristo Bio-Tech & Lifescience Ltd Overview
About ARISTO
Aristo Bio-Tech & Life science is a dedicated Crop Protection company providing Best Quality manufacturing, formulation, supply and packaging job work services for various Pesticides: Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals in India as well as for Export.
Aristo Bio-Tech & Lifescience Ltd Historical Performance
Aristo Bio-Tech & Lifescience Ltd Fundamentals
Aristo Bio-Tech & Lifescience Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 364.18 | 318.54 | 245.33 | 218.19 | 166.03 |
| EBITDA | 16.51 | 9.73 | 8.67 | 9.03 | 5.44 |
| Net Profit | 7.18 | 4.11 | 3.90 | 3.56 | 1.43 |
| EPS | 10.55 | 6.04 | 5.72 | 5.23 | 2.87 |
Aristo Bio-Tech & Lifescience Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 111.53 |
| Resistance 1 (R1) | 112.93 |
| Pivot Point | 112.47 |
Aristo Bio-Tech & Lifescience Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 23-Sep-2026 | 30-May-2026 | 23-Sep-2026 | Final | ₹0.60 |
| 01-Sep-2025 | 29-May-2025 | 01-Sep-2025 | Final | ₹0.50 |
| 13-Sep-2024 | 27-May-2024 | 13-Sep-2024 | Final | ₹0.40 |
| 15-Sep-2023 | 27-May-2023 | 15-Sep-2023 | Final | ₹0.25 |
ARISTO Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Narendra Singh Barhat | Chairman & Managing Director |
| Kusum Narendra Singh Barhat | Executive Directorector |
| Ketankumar Harkantbhai Joshi | Whole Time Director |
Aristo Bio-Tech & Lifescience Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| UPL LtdUPL | ₹550.05+0.08% | ₹51,802.16 | 25.84 | 5.54% |
| P I Industries LtdPIIND | ₹2,400.00+0.27% | ₹46,368.09 | 31.96 | 11.76% |
| Sumitomo Chemical India LtdSUMICHEM | ₹446.35-0.74% | ₹19,746.21 | 37.15 | 16.02% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aristo Bio-Tech & Lifescience Ltd today is ₹105.85 on NSE and ₹105.85 on BSE.
- The 52-week high of Aristo Bio-Tech & Lifescience Ltd is ₹136.00, while the 52-week low is ₹74.30.
- The current market capitalisation of Aristo Bio-Tech & Lifescience Ltd is approximately ₹72 crore.
- The P/E (Price-to-Earnings) ratio of Aristo Bio-Tech & Lifescience Ltd is 10.03. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aristo Bio-Tech & Lifescience Ltd is 1.63. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aristo Bio-Tech & Lifescience Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ARISTO on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aristo Bio-Tech & Lifescience Ltd has delivered a return of approximately 38.37%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aristo Bio-Tech & Lifescience Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 73.42% promoters, 0.00% FIIs, 0.00% DIIs, and 24.28% public shareholders.

